1
|
Althuis MD, Dozier JM, Anderson WF, Devesa
SS and Brinton LA: Global trends in breast cancer incidence and
mortality 1973–1997. Int J Epidemiol. 34:405–412. 2005.PubMed/NCBI
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
3
|
Hortobagyi GN, de la Salazar GJ, Pritchard
K, et al: The global breast cancer burden: variations in
epidemiology and survival. Clin Breast Cancer. 6:391–401. 2005.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Forbes JF: The incidence of breast cancer:
the global burden, public health considerations. Semin Oncol.
24(Suppl 1): S1-20–S1-35. 1997.PubMed/NCBI
|
5
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008: Cancer Incidence and
Mortality Worldwide IARC Cancerbase No, 10. International Agency
for Research on Cancer; Lyon: 2010
|
6
|
Khatib OMN: Guidelines for the Early
Detection and Screening of Breast Cancer. EMRO Technical
Publications Series, 30. WHO World Health Organization; Cairo:
2006
|
7
|
Autier P1, Boniol M, La Vecchia C, Vatten
L, Gavin A, Héry C and Heanue M: Disparities in breast cancer
mortality trends between 30 European countries: retrospective trend
analysis of WHO mortality database. BMJ. 341:c36202010. View Article : Google Scholar
|
8
|
Bosetti C, Bertuccio P, Malvezzi M, et al:
Cancer mortality in Europe, 2005–2009 and an overview of trends
since 1980. Ann Oncol. 24:2657–2671. 2013.
|
9
|
Levi F, Bosetti C, Lucchini F, Negri E and
La Vecchia C: Monitoring the decrease in breast cancer mortality in
Europe. Eur J Cancer Prev. 14:497–502. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Tyczynski JE, Plesko I, Aareleid T, et al:
Breast cancer mortality patterns and time trends in 10 new EU
member states: mortality declining in young women, but still
increasing in the elderly. Int J Cancer. 112:1056–1064. 2004.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Botha JL, Bray F, Sankila R and Parkin DM:
Breast cancer incidence and mortality trends in 16 European
countries. Eur J Cancer. 39:1718–1729. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Autier P, Boniol M, Gavin A and Vatten LJ:
Breast cancer mortality in neighbouring European countries with
different levels of screening but similar access to treatment:
trend analysis of WHO mortality database. BMJ. 343:d44112011.
View Article : Google Scholar
|
13
|
Fielder HM, Warwick J, Brook D, et al: A
case-control study to estimate the impact on breast cancer death of
the breast screening programme in Wales. J Med Screen. 11:194–198.
2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Allgood PC, Warwick J, Warren RM, Day NE
and Duffy SW: A case-control study of the impact of the East
Anglian breast screening programme on breast cancer mortality. Br J
Cancer. 98:206–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gabe R, Tryggvadóttir L, Sigfússon BF,
Olafsdóttir GH, Sigurdsson K and Duffy SW: A case-control study to
estimate the impact of the Icelandic population-based mammography
screening program on breast cancer death. Acta Radiol. 48:948–955.
2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Puliti D, Miccinesi G, Collina N, et al:
Effectiveness of service screening: a case control study to assess
breast cancer mortality reduction. Br J Cancer. 99:423–427. 2008.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Roder D, Houssami N, Farshid G, et al:
Population screening and intensity of screening are associated with
reduced breast cancer mortality: evidence of efficacy of
mammography screening in Australia. Breast Cancer Res Treat.
108:409–416. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Paap E, Holland R, den Heeten GJ, et al: A
remarkable reduction of breast cancer deaths in screened versus
unscreened women: a case-referent study. Cancer Causes Control.
21:1569–1573. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Puliti D and Zappa M: Breast cancer
screening: are we seeing the benefit? BMC Med. 10:1062012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
L 327/34 Council Recommendation of 2
December 2003 on cancer screening (2003/878/EC). Official Journal
of the European Union. European Union; Brussels: pp.
L327/34–L327/37. 16–12. 2003
|
21
|
Vainio H and Bianchini F: IARC Handbooks
of Cancer Prevention Volume 7 Breast Cancer Screening. IARC Press,
International Agency for Research on Cancer; Lyon: 2002
|
22
|
Njor S, Nyström L, Moss S, et al: Breast
cancer mortality in mammographic screening in Europe: a review of
incidence-based mortality studies. J Med Screen. 19(Suppl 1):
S33–S41. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
International Cancer Screening Network;
Atlanta: Breast Cancer Screening Programs in 26 ICSN Countries,
2012: Organization, Policies, and Program Reach. http://appliedresearch.cancer.gov/icsn/breast/screening.html.
Accessed Nov 23 2013
|
24
|
Broeders M, Moss S, Nyström L, et al: The
impact of mammographic screening on breast cancer mortality in
Europe: a review of observational studies. J Med Screen. 19(Suppl
1): 14–25. 2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Marmot MG, Altman DG, Cameron DA, Dewar
JA, Thompson SG and Wilcox M: The benefits and harms of breast
cancer screening: an independent review. Lancet. 380:1778–1786.
2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Marmot MG, Altman DG, Cameron DA, Dewar
JA, Thompson SG and Wilcox M: The benefits and harms of breast
cancer screening: an independent review. Br J Cancer.
108:2205–2240. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Foca F, Mancini S, Bucchi L, et al:
Decreasing incidence of late-stage breast cancer after the
introduction of organized mammography screening in Italy. Cancer.
119:2022–2028. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Timmers JM, den Heeten GJ, Adang EM, Otten
JD, Verbeek AL and Broeders MJ: Dutch digital breast cancer
screening: implications for breast cancer care. Eur J Public
Health. 22:925–929. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Houssami N, Lord SJ and Ciatto S: Breast
cancer screening: emerging role of new imaging techniques as
adjuncts to mammography. Med J Aust. 190:493–497. 2009.PubMed/NCBI
|
30
|
Beemsterboer PM, de Koning HJ, Warmerdam
PG, et al: Prediction of the effects and costs of breast-cancer
screening in Germany. Int J Cancer. 58:623–628. 1994. View Article : Google Scholar : PubMed/NCBI
|
31
|
De Koning H: Breast cancer screening;
cost-effective in practice? Eur J Radiol. 33:32–37. 2000.PubMed/NCBI
|
32
|
Hakama M, Pukkala E, Heikkilä M and Kallio
M: Effectiveness of the public health policy for breast cancer
screening in Finland: population based cohort study. BMJ.
314:864–867. 1997. View Article : Google Scholar : PubMed/NCBI
|
33
|
Hakama M, Pukkala E, Söderman B and Day N:
Implementation of screening as a public health policy: issues in
design and evaluation. J Med Screen. 6:209–216. 1999. View Article : Google Scholar : PubMed/NCBI
|
34
|
Vutuc C, Waldhoer T and Haidinger G:
Breast cancer trends: opportunistic screening in Austria versus
controlled screening in Finland and Sweden. Eur J Cancer Prev.
15:343–346. 2006. View Article : Google Scholar : PubMed/NCBI
|
35
|
Oberaigner W, Daniaux M, Geiger-Gritsch S,
Knapp R, Siebert U and Buchberger W: Introduction of organised
mammography screening in Tyrol: results following first year of
complete rollout. BMC Public Health. 11:6732011.PubMed/NCBI
|
36
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, et al: Cancer incidence and mortality patterns
in Europe: estimates for 40 countries in 2012. Eur J Cancer.
49:1374–1403. 2013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Verleye L, Desomer A, Gailly J and Robays
J: Dépistage du cancer du sein: comment identifier les femmes
exposées à un risque accru - Quelles techniques d’imagerie
utiliser? Good Clinical Practice (GCP), . Bruxelles: Centre fédéral
d’expertise des soins de santé (KCE). KCE Reports 172B
D/2011/10273/91. 2011
|
38
|
Hermesse J: Résultats de 6 ans de dépistag
eorganisé du cancer du sein en Belgique. [Internet] Communiqué par
l’Agence intermutualiste. Education Santé. 261:november. 2010, pp.
5–6, http://www.educationsante.be/es/imprarticle.php?id=1309.
Accessed Oct 18, 2013
|
39
|
Center for Protection of Rights in Health
Care (CZPZ). Sophia (Bulgary): Screening examinations for breast
cancer. http://www.czpz.org/index.php?option=com_content&view=category&id=50&Itemid=107&lang=en.
Accessed Nov 24, 2013
|
40
|
Tesic V, Kolaric B, Znaor A, Kuna SK and
Brkljacic B: Mammographic density and estimation of breast cancer
risk in intermediate risk population. Breast J. 19:71–78. 2013.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Kelava I, Tomičić K, Kokić M, et al:
Breast and gynecological cancers in Croatia, 1988–2008. Croat Med
J. 53:100–108. 2012.
|
42
|
Brnić Z, Blašković D, Klasić B, et al:
Image quality of mammography in Croatian nationwide screening
program: comparison between various types of facilities. Eur J
Radiol. 81:e478–e485. 2012.PubMed/NCBI
|
43
|
Hadjisavvas A, Loizidou MA, Middleton N,
et al: An investigation of breast cancer risk factors in Cyprus: a
case control study. BMC Cancer. 10:1–10. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Ministry of Health Cyprus. Cyprus: breast
cancer screening. http://www.moh.gov.cy.
Accessed Oct 15, 2013
|
45
|
Majek O, Danes J, Skovajsova M, et al:
Breast cancer screening in the Czech Republic: time trends in
performance indicators during the first seven years of the
organised programme. BMC Public Health. 11:2882011.PubMed/NCBI
|
46
|
Eurostat Breast Cancer. Eurostat screening
statistics. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Breast_cancer_screening_statistics.
Accessed 25 Oct, 2013
|
47
|
Domingo L, Jacobsen KK, von Euler-Chelpin
M, et al: Seventeen-years overview of breast cancer inside and
outside screening in Denmark. Acta Oncol. 52:48–56. 2013.PubMed/NCBI
|
48
|
Jørgensen KJ, Zahl PH and Gøtzsche PC:
Breast cancer mortality in organised mammography screening in
Denmark: comparative study. BMJ. 340:c12412010.PubMed/NCBI
|
49
|
Matsalu M; Ministry of Health Estonia.
Crossing borders in breast cancer screening. First International
Symposium; October 28 & 29 - 2010; Amsterdam. The Netherland.
http://www.breastcancerscreening.eu/images/stories/PDF's/101029_05_Presentation_Estonia_Meeli_Matsalu_Symposium_Crossing_borders.pdf.
Accessed Sep 17, 2013
|
50
|
Héry C, Ferlay J, Boniol M and Autier P:
Quantification of changes in breast cancer incidence and mortality
since 1990 in 35 countries with Caucasian-majority populations. Ann
Oncol. 19:1187–1194. 2008.PubMed/NCBI
|
51
|
Ministry of Health Finland. Breast Cancer
screening. Finland: http://www.stm.fi/sosiaali_ja_terveyspalvelut/terveyspalvelut/seulonnat.
Accessed Oct 16, 2013
|
52
|
Séradour B: Breast cancer screening in
France: an overview in 2009. Rev Prat. 60:191–199. 2010.(In
French).
|
53
|
Biesheuvel C, Weigel S and Heindel W:
Mammography screening: evidence, history and current practice in
Germany and other European countries. Breast Care (Basel).
6:104–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
54
|
Tsakiroglou M, Bakalis M, Valasoulis G,
Paschopoulos M, Koliopoulos G and Paraskevaidis E: Women’s
knowledge and utilization of gynecological cancer prevention
services in the Northwest of Greece. Eur J Gynaecol Oncol.
32:178–181. 2011.
|
55
|
Boncz I, Sebestyén A, Pintér I, Battyány I
and Ember I: The effect of an organized, nationwide breast cancer
screening programme on non-organized mammography activities. J Med
Screen. 15:14–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
56
|
Minister for Health and Children Ireland.
National Cancer Screening Service. http://www.cancerscreening.ie/.
Accessed Mar, 2014
|
57
|
Zorzi M, Fedato C, Grazzini G, et al:
Screening for colorectal cancer in Italy, 2010 survey. Epidemiol
Prev. 36(Suppl 1): 55–77. 2012.
|
58
|
Ministry of Health Latvia. Breast cancer
screening. http://www.vmnvd.gov.lv/lv/aktualitates.
Accessed Nov 10, 2013
|
59
|
Breast Cancer Screening Germany 11/17/2006
in European-Hospital. http://www.european-hospital.com/en/article/743-Breast_cancer_screening.html.
Accessed Oct 12, 2013
|
60
|
Autier P, Shannoun F, Scharpantgen A, et
al: A breast cancer screening programme operating in a liberal
health care system: the Luxembourg Mammography Programme,
1992–1997. Int J Cancer. 97:828–832. 2002.PubMed/NCBI
|
61
|
Shannoun F, Schanck JM, Scharpantgen A,
Wagnon MC, Ben Daoud M and Back C: Organisational aspects of
mammography screening in digital settings: first experiences of
Luxembourg. Radiat Prot Dosimetry. 129:195–198. 2008. View Article : Google Scholar
|
62
|
Szynglarewicz B, Matkowski R, Kasprzak P,
et al: The effectiveness of population-based breast cancer
screening programme. Pol Merkur Lekarski. 26:117–120. 2009.(In
Polish).
|
63
|
Cancer.gov. Atlanta: International Cancer
Screening Network; Policies on Number of Views, Double-Reading, and
Computer Aided Detection for Breast Cancer Screening Programs in 26
ICSN Countries. 2012, http://appliedresearch.cancer.gov/icsn/breast/policies.reading.html.
Accessed Oct 23, 2013
|
64
|
Ministry of Health Portugal. Breast cancer
screening. http://www.portaldasaude.pt/portal/conteudos/a+saude+em+portugal/noticias/rastreio+estremoz+14.htm.
Accessed Dec 11, 2013
|
65
|
Oncologic Society Romania. Breast cancer
screening. http://www.srccjro.org/.
Accessed Dec 20, 2013
|
66
|
Dora Project. Breast cancer screening
Slovenia. http://www.dpor.si/en/?page_id=97.
Accessed Dec 18, 2013
|
67
|
Ascunce N, Salas D, Zubizarreta R, et al:
Cancer screening in Spain. Ann Oncol. 21(Suppl 3): iii43–51. 2010.
View Article : Google Scholar
|
68
|
Pubblic Health England: NHS. Breast cancer
screening programme. http://www.cancerscreening.nhs.uk/breastscreen/digital-mammography.html.
Accessed Dec 16, 2013
|
69
|
Moser K, Sellars S, Wheaton M, et al:
Extending the age range for breast screening in England: pilot
study to assess the feasibility and acceptability of randomization.
J Med Screen. 18:96–102. 2011. View Article : Google Scholar : PubMed/NCBI
|
70
|
Buerger H, Otterbach F, Simon R, Schäfer
KL, Poremba C and Diallo R: Different genetic pathways in the
evolution of invasive breast cancer are associated with distinct
morphological subtypes. J Pathol. 189:521–526. 1999. View Article : Google Scholar : PubMed/NCBI
|
71
|
Buerger H, Schmidt H, Beckmann A, Zänker
KS, Boecker W and Brandt B: Genetic characterisation of invasive
breast cancer: a comparison of CGH and PCR based multiplex
microsatellite analysis. J Clin Pathol. 54:836–840. 2001.
View Article : Google Scholar : PubMed/NCBI
|
72
|
Kao J, Salari K, Bocanegra M, et al:
Molecular profiling of breast cancer cell lines defines relevant
tumor models and provides a resource for cancer gene discovery.
PLoS One. 4:e61462009.PubMed/NCBI
|
73
|
Prat A, Parker JS, Karginova O, et al:
Phenotypic and molecular characterization of the claudin-low
intrinsic subtype of breast cancer. Breast Cancer Res. 12:R682010.
View Article : Google Scholar : PubMed/NCBI
|
74
|
Banegas MP, Tao L, Altekruse S, et al:
Heterogeneity of breast cancer subtypes and survival among Hispanic
women with invasive breast cancer in California. Breast Cancer Res
Treat. 144:625–634. 2014. View Article : Google Scholar : PubMed/NCBI
|
75
|
Altobelli E, Lattanzi A, Paduano R,
Varassi G and di Orio F: Colorectal cancer prevention in Europe:
burden of disease and status of screening programs. Prev Med.
62C:132–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
76
|
James TM, Greiner KA, Ellerbeck EF, Feng C
and Ahluwalia JS: Disparities in colorectal cancer screening: a
guideline-based analysis of adherence. Ethn Dis. 16:228–233.
2006.PubMed/NCBI
|